文献速递流行病学与生物统计临床试验与 GCP

外科随机对照试验安慰剂组应答的幅度与时间变化:系统综述与荟萃分析

The magnitude and temporal changes of response in the placebo arm of surgical randomized controlled trials: a systematic review and meta-analysis.
PubMed 文献 · Trials · 2016-12-12

该系统综述与荟萃分析检索MEDLINE、EMBASE、Cochrane对照试验中央注册库和ClinicalTrials.gov(建库至2015年10月20日),纳入47项外科随机对照试验(共1744例受试者),评估安慰剂组应答幅度及其受随访时长影响。结果显示,主观结局的安慰剂组应答较大(汇总效应量0.64,95%CI 0.5至0.8),且不随随访时长变化;客观结局的效应较小(0.11,95%CI 0.04至0.26)或在各时间点无显著差异。

要点

  • 主观结局的安慰剂组汇总效应量大(0.64,95%CI 0.5至0.8),且在整个盲法随访期间不随时间变化。
  • 客观结局的安慰剂组效应小(0.11,95%CI 0.04至0.26)或在各时间点无显著差异。
  • 随访时长对安慰剂应答幅度无显著影响,结局主观性是安慰剂应答最强的预测因素。

核心结论

  • 外科试验中主观结局的安慰剂应答较大,且在整个盲法随访期间表现为不随时间变化的效应。
  • 因此,此类结局的安慰剂应答不能通过在不同时间点进行评估来最小化。
  • 分析提示客观结局可能更适合作为试验终点。
  • 若主观结局为主要关注点,则需设置安慰剂组以控制安慰剂应答。

研究设计与样本

  • 系统综述与荟萃分析,检索MEDLINE、EMBASE、Cochrane对照试验中央注册库和ClinicalTrials.gov,检索时间自建库至2015年10月20日。
  • 纳入比较外科干预与安慰剂疗效的研究,不限定疾病、干预、结局或患者人群。
  • 数据库检索返回88项研究,其中41项无法计算标准化均数差(SMD),最终47项试验(共1744例受试者)纳入分析。
  • 使用SMD估计安慰剂应答幅度,采用随机效应荟萃分析合并研究估计值,通过分层分析和荟萃回归评估异质性来源。

主要发现

  • 在所分析的试验内,安慰剂应答无时间变化。
  • 荟萃回归分析显示,随访时长对安慰剂应答幅度无显著影响,结局主观性是安慰剂应答最强的预测因素。
  • 主观结局研究的安慰剂组汇总效应量大(0.64,95%CI 0.5至0.8),且无论随访时长如何均显著异于零。
  • 客观结局的效应小(0.11,95%CI 0.04至0.26)或在所有时间点均无显著差异。

临床怎么用

  • 作者认为,对于主观结局,不能通过在不同时间点进行评估来最小化安慰剂应答。
  • 作者认为,客观结局可能更适合作为试验终点。
  • 作者认为,若主观结局为主要关注点,则需设置安慰剂组以控制安慰剂应答。

局限性

  • 数据库检索返回88项研究,但其中41项无法计算SMD,仅47项试验纳入分析。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND: Understanding changes in the placebo arm is essential for correct design and interpretation of randomized controlled trials (RCTs). It is assumed that placebo response, defined as the total improvement in the placebo arm of surgical trials, is large; however, its precise magnitude and properties remain to be characterized. To the best of our knowledge, the temporal changes in the placebo arm have not been investigated. The aim of this paper was to determine, in surgical RCTs, the magnitude of placebo response and how it is affected by duration of follow-up. METHODS: The databases of MEDLINE, EMBASE, the Cochrane Central Register of Controlled Trials and ClinicalTrials.gov were searched from their inception to 20 October 2015 for studies comparing the efficacy of a surgical intervention with placebo. Inclusion was not limited to any particular condition, intervention, outcome or patient population. The magnitude of placebo response was estimated using standardized mean differences (SMDs). Study estimates were pooled using random effects meta-analysis. Potential sources of heterogeneity were evaluated using stratification and meta-regression. RESULTS: Database searches returned 88 studies, but for 41 studies SMDs could not be calculated, leaving 47 trials (involving 1744 participants) eligible for inclusion. There were no temporal changes in placebo response within the analysed trials. Meta-regression analysis showed that duration of follow-up did not have a significant effect on the magnitude of the placebo response and that the strongest predictor of placebo response was subjectivity of the outcome. The pooled effect in the placebo arm of studies with subjective outcomes was large (0.64, 95% CI 0.5 to 0.8) and remained significantly different from zero regardless of the duration of follow-up, whereas for objective outcomes, the effect was small (0.11, 95% CI 0.04 to 0.26) or non-significant across all time points. CONCLUSIONS: This is the first study to investigate the temporal changes of placebo response in surgical trials and the first to investigate the sources of heterogeneity of placebo response. Placebo response in surgical trials was large for subjective outcomes, persisting as a time-invariant effect throughout blinded follow-up. Therefore, placebo response cannot be minimized in these types of outcomes through their appraisal at alternative time points. The analyses suggest that objective outcomes may be preferable as trial end-points. Where subjective outcomes are of primary interest, a placebo arm is necessary to control for placebo response.

来源:Trials,查看原文。版权归原作者所有。

引用

  1. Wartolowska KA, Feakins BG, Collins GS, et al. The magnitude and temporal changes of response in the placebo arm of surgical randomized controlled trials: a systematic review and meta-analysis. Trials. 2016. PMID: 27955685

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。